[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2012 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 47.45%
YoY- -1.77%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 75,826 37,837 135,310 99,932 70,412 36,057 138,132 -32.98%
PBT 21,963 8,956 35,298 26,298 17,906 8,869 34,728 -26.34%
Tax -4,575 -2,257 -9,284 -6,281 -4,331 -2,161 -8,023 -31.25%
NP 17,388 6,699 26,014 20,017 13,575 6,708 26,705 -24.89%
-
NP to SH 17,388 6,699 26,014 20,017 13,575 6,708 26,705 -24.89%
-
Tax Rate 20.83% 25.20% 26.30% 23.88% 24.19% 24.37% 23.10% -
Total Cost 58,438 31,138 109,296 79,915 56,837 29,349 111,427 -34.99%
-
Net Worth 187,340 176,143 169,354 167,965 162,400 170,824 163,783 9.38%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 5,550 - 19,434 - 4,858 - 24,983 -63.35%
Div Payout % 31.92% - 74.71% - 35.79% - 93.56% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 187,340 176,143 169,354 167,965 162,400 170,824 163,783 9.38%
NOSH 138,770 138,695 138,815 138,814 138,803 138,881 138,799 -0.01%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 22.93% 17.70% 19.23% 20.03% 19.28% 18.60% 19.33% -
ROE 9.28% 3.80% 15.36% 11.92% 8.36% 3.93% 16.31% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 54.64 27.28 97.47 71.99 50.73 25.96 99.52 -32.97%
EPS 12.53 4.83 18.74 14.42 9.78 4.83 19.24 -24.88%
DPS 4.00 0.00 14.00 0.00 3.50 0.00 18.00 -63.34%
NAPS 1.35 1.27 1.22 1.21 1.17 1.23 1.18 9.39%
Adjusted Per Share Value based on latest NOSH - 138,836
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 7.88 3.93 14.07 10.39 7.32 3.75 14.36 -32.99%
EPS 1.81 0.70 2.70 2.08 1.41 0.70 2.78 -24.89%
DPS 0.58 0.00 2.02 0.00 0.51 0.00 2.60 -63.25%
NAPS 0.1948 0.1831 0.1761 0.1746 0.1688 0.1776 0.1703 9.38%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 2.38 2.23 2.13 2.36 2.23 2.40 2.02 -
P/RPS 4.36 8.17 2.19 3.28 4.40 9.24 2.03 66.54%
P/EPS 18.99 46.17 11.37 16.37 22.80 49.69 10.50 48.49%
EY 5.26 2.17 8.80 6.11 4.39 2.01 9.52 -32.69%
DY 1.68 0.00 6.57 0.00 1.57 0.00 8.91 -67.15%
P/NAPS 1.76 1.76 1.75 1.95 1.91 1.95 1.71 1.94%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/08/13 27/05/13 25/02/13 23/11/12 16/08/12 17/05/12 22/02/12 -
Price 2.44 2.51 2.17 2.28 2.38 2.38 2.12 -
P/RPS 4.47 9.20 2.23 3.17 4.69 9.17 2.13 63.98%
P/EPS 19.47 51.97 11.58 15.81 24.34 49.28 11.02 46.19%
EY 5.14 1.92 8.64 6.32 4.11 2.03 9.08 -31.59%
DY 1.64 0.00 6.45 0.00 1.47 0.00 8.49 -66.61%
P/NAPS 1.81 1.98 1.78 1.88 2.03 1.93 1.80 0.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment